MRD / Recurrence Monitoring Test
Primary and Metastatic CNS Malignancies
Development/ValidationActive
Key Facts
Indication
Primary and Metastatic CNS Malignancies
Phase
Development/Validation
Status
Active
Company
About Belay Diagnostics
Belay Diagnostics is a private, pre-revenue diagnostics company pioneering CSF liquid biopsy for CNS cancers. The company has developed three proprietary tests designed to detect and genomically profile tumors from cerebrospinal fluid, addressing the significant limitations of current standards like MRI, cytology, and invasive surgical biopsies. Founded by a team of neurosurgeons, scientists, and entrepreneurs with deep expertise in neuro-oncology and diagnostics, Belay is positioned to tap into a substantial unmet need in neuro-oncology. Its success hinges on clinical validation, market adoption, and navigating the complex reimbursement landscape for novel diagnostic tests.
View full company profileOther Primary and Metastatic CNS Malignancies Drugs
| Drug | Company | Phase |
|---|---|---|
| Diagnostic & Molecular Profiling Test | Belay Diagnostics | Development/Validation |
| Therapy Selection & Monitoring Test | Belay Diagnostics | Development/Validation |